Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 diabetes - obesity and GLP-1 therapyca-mccqe1ca-ccfpca-rcpsc-im

A 32-year-old woman with a BMI of 36 kg/m² and newly diagnosed type 2 diabetes asks about weight-loss medications. She has no cardiovascular disease, normal renal function, and is already on metformin. According to Diabetes Canada, which medication class both improves glycaemic control and has proven weight-loss benefit?

Educational content. Not a substitute for clinical judgement or local policy.